Open buy · week 8 · US stocks
Pfizer drops 3% and slips back under its 20-day average after an unconfirmed high
Our view last week
Pfizer stock closed the week up 3.7% after touching its 20-day moving average, in the 28 area, and bouncing 3% off it. After two weeks with sellers ahead, buyers took the lead again in the weekly bar, and the last session traded 96% of its volume on the buy side. Technical analysis shows a trend gaining conviction while signal strength eases: the buy signal is in week 7 and the trade is up 7.14%.
This week's summary
Last week it bounced off its 20-day average; this week it gave that ground back. Pfizer stock fell 3% and slipped under that average, in the 28 area, after a new 7-day high the weekly close failed to confirm. The technical analysis still holds: ADX has risen for 9 weeks, MACD sits above its Signal line and money flow has been positive for 12. Among the weekly buy signals on US stocks, this one is in week 8 and the trade is up 3.89%.
IQS Phase
61
ordinary
Signal Strength
47
medium · weak
Sizing
REDUCED
Ranking
#65 / 93
US stocks in progress
Trade P&L %
+3.89%
from signal to date, no stop loss
Pfizer (PFE) weekly chart — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
Rank position
ranks 65th among the 93 Longs already running for US stocks in our ranking, with a signal strength of 47 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -2.65% · monthly -3.91%
PFE belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content